PharmaRoth Labs, Inc.
ROTH · OTC
6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $1 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $83 | $30 | $78 | $172 |
| Inventory | $150 | $102 | $45 | $35 |
| Other Curr. Assets | $70 | $74 | $85 | $78 |
| Total Curr. Assets | $304 | $207 | $209 | $291 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $304 | $207 | $209 | $291 |
| Liabilities | – | – | – | – |
| Payables | $118 | $38 | $52 | $40 |
| Short-Term Debt | $250 | $250 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $69 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $495 | $412 | $625 | $541 |
| Total Curr. Liab. | $863 | $700 | $678 | $650 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $863 | $700 | $678 | $650 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $391 | $379 | $349 | $309 |
| Retained Earnings | -$2,895 | -$2,803 | -$2,570 | -$2,209 |
| AOCI | $10 | $10 | $6 | -$0 |
| Other Equity | $1,944 | $1,931 | $1,756 | $1,542 |
| Total Equity | -$549 | -$483 | -$459 | -$358 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$10 | -$10 | -$10 | -$1 |
| Total Liab. & Tot. Equity | $304 | $207 | $209 | $291 |
| Net Debt | $249 | $249 | -$1 | -$6 |